血糖控制与胰岛素改善2型糖尿病患者的肌肉量和步速:MUSCLES-DM研究
该纵向观察研究纳入588例日本2型糖尿病患者,随访1年发现,HbA1c降低≥1%与骨骼肌质量指数和步速的增加独立相关,基线使用胰岛素与骨骼肌质量指数变化独立相关。研究提示纠正血糖控制不佳和使用胰岛素可能有助于预防肌少症。
要点
- HbA1c降低≥1%与骨骼肌质量指数和步速增加独立相关。
- 基线使用胰岛素是骨骼肌质量指数变化的独立因素。
- 随访期间肌少症频率仅轻微增加,握力无显著变化。
核心结论
- 纠正血糖控制不佳和使用胰岛素与日本2型糖尿病患者骨骼肌质量或步速的增加显著相关。
研究设计与样本
- 观察性纵向研究,纳入588例日本糖尿病患者,完成1年随访的肌少症和临床数据测量,数据来自MUSCLES-DM多中心研究。
主要发现
- 随访期间肌少症频率轻微增加,骨骼肌质量指数、握力和步速均值无变化。
- 按HbA1c变化程度分5组,HbA1c降低≥1%的患者骨骼肌质量指数显著增加,步速有类似结果,但握力无类似结果。
- 多元线性回归显示HbA1c降低≥1%是骨骼肌质量指数和步速变化的独立决定因素。
- 基线使用胰岛素是骨骼肌质量指数变化的独立因素。
关键数值与推荐
- HbA1c降低≥1%与骨骼肌质量指数和步速增加独立相关。
- 基线使用胰岛素与骨骼肌质量指数变化独立相关。
临床怎么用
- 对血糖控制不佳的2型糖尿病患者,积极降糖使HbA1c降低≥1%可能有助于改善骨骼肌质量和步速。
- 基线使用胰岛素可能对骨骼肌质量有有利影响,但需结合患者具体情况评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Type 2 diabetes is a risk factor for sarcopenia. Evidence on the prevention of sarcopenia using blood glucose-lowering therapy is limited. We aimed to examine the relationship between changes in glycemic control and sarcopenia and the effect of antidiabetic agents against sarcopenia in patients with type 2 diabetes. DESIGN: We conducted an observational longitudinal study. SETTING AND PARTICIPANTS: In total, 588 Japanese patients with diabetes of an ongoing multicenter study completed 1-year follow-up measurements for sarcopenia and clinical data. METHODS: The data set of the Multicenter Study for Clarifying Evidence for Sarcopenia in patients with Diabetes Mellitus (the MUSCLES-DM study) was analyzed. RESULTS: During the follow-up period, the frequency of sarcopenia marginally increased, and the means of skeletal muscle mass index (SMI), handgrip strength, and gait speed did not show any changes. However, on dividing into 5 groups depending on the degree of changes in glycated hemoglobin (HbA1c) value, the patients with a decrease of ≥1% in HbA1c exhibited a significant increase in SMI. Our analysis revealed similar results for gait speed but not handgrip strength. Using the multiple linear regression model, we identified that a ≥1% decrease in HbA1c value was an independent determinant of the changes in SMI and gait speed. We also determined that insulin use at baseline was an independent factor for the changes in SMI. CONCLUSIONS AND IMPLICATIONS: Correction of poor glycemic control and use of insulin were significantly associated with the increase in skeletal muscle mass or gait speed in Japanese patients with type 2 diabetes. The current finding increases our understanding of the importance of glycemic control for the prevention of cardiovascular diseases and sarcopenia.
引用
- Sugimoto K, Ikegami H, Takata Y, et al. Glycemic Control and Insulin Improve Muscle Mass and Gait Speed in Type 2 Diabetes: The MUSCLES-DM Study. J Am Med Dir Assoc. 2020. PMID: 33278348. doi:10.1016/j.jamda.2020.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。